Search Results
Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies
Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular Risks
PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in Hyperlipidemia
What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action)
Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD
Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update
Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies
Straight From the Experts: Modernizing Hyperlipidemia Management With PCSK9-Targeting Agents
PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16
Updates in Guidelines for Chronic Conditions: Diagnosis, Management & Treatment of Dyslipidemia
Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant High-Risk ASCVD Patients
Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference
